Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.61 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.61 |
| ▸ | TSHR | P16473 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.61 |
| ▸ | MEN1 | O00255 | 1/20 | 0.61 |
| ▸ | MAPT | P10636 | 1/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.61 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.54 |
| ▸ | UGT2B7 | P16662 | 7/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.41 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.38 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.36 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | IDO1 | P14902 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9880617 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL31139943 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL8611875 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL1105231 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL3112011 | 1.00 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL19958385 | 0.87 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL27017541 | 0.87 | ALDH1A1 (0.61) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL385019 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL10101191 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 | |
| SCHEMBL9880760 | 0.87 | ALDH1A1 (0.57) | ALDH1A1CYP3A4CYP2C9TSHRCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 161 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210381013-A1 | ENZYMATIC CYCLIZATION OF HOMOFARNESYLIC ACID | BASF SE (DE) | 2021-12-09 | — | — | US | claimed |
| EP-3816297-A1 | BIOCATALYTIC CYCLISING POLYUNSATURATED CARBOXYLIC ACID COMPOUNDS | BASF SE (DE) | 2021-05-05 | — | — | EP | claimed |
| EP-3417067-B1 | ENZYMATIC CYCLISATION OF HOMOFARNESYLIC ACID | BASF SE (DE) | 2020-11-18 | — | — | EP | claimed |
| EP-3417067-A1 | ENZYMATIC CYCLIZATION OF HOMOFARNESYLIC ACID | BASF SE (DE) | 2018-12-26 | — | — | EP | claimed |
| WO-2017140909-A1 | ENZYMATIC CYCLIZATION OF HOMOFARNESYLIC ACID | BASF SE (DE) | 2017-08-24 | — | — | WO | claimed |
| EP-2910545-B1 | METHOD FOR PRODUCING N,N-DIALKYLHOMOFARNESIC ACID AMIDE | KAO CORP (JP) | 2017-04-12 | — | — | EP | claimed |
| US-9518037-B2 | Method for producing N,N-dialkylhomofarnesic acid amide | KAO CORPORATION (JP) | 2016-12-13 | — | — | US | claimed |
| US-20160168109-A1 | METHOD FOR PRODUCING N,N-DIALKYLHOMOFARNESIC ACID AMIDE | KAO CORPORATION (JP) | 2016-06-16 | — | — | US | claimed |
| EP-2910545-A1 | METHOD FOR PRODUCING N,N-DIALKYLHOMOFARNESIC ACID AMIDE | Kao Corporation (JP) | 2015-08-26 | — | — | EP | claimed |
| US-8536349-B2 | Cyclic ethers | GIVAUDAN S.A. (CH) | 2013-09-17 | — | — | US | claimed |
| WO-1995015321-A1 | PROCESS FOR PRODUCING 8ALPHA,12-OXIDO-13,14,15,16-TETRANORLABDANE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1995-06-08 | — | — | WO | claimed |
| EP-0467905-B1 | PROCESS FOR THE STEREO-SELECTIVE PRODUCTION OF 8$g(a),12-OXIDO-13,14,15,16-TETRANORLABDANE | HENKEL KGAA (DE) | 1994-09-07 | — | — | EP | claimed |
| EP-0596923-A1 | METHOD OF PREPARING 8,12-OXIDO-13,14,15,16-TETRANORLABDANE. | HENKEL KGAA (DE) | 1994-05-18 | — | — | EP | claimed |
| US-5274134-A | Process for the stereoselective preparation of 8α, 12-oxido-13, 14,15, 16-tetranorlabdane | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1993-12-28 | — | — | US | claimed |
| WO-1993002073-A1 | METHOD OF PREPARING 8,12-OXIDO-13,14,15,16-TETRANORLABDANE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1993-02-04 | — | — | WO | claimed |
| EP-0467905-A1 | PROCESS FOR THE STEREO-SELECTIVE PRODUCTION OF 8-g(a),12-OXIDO-13,14,15,16-TETRANORLABDANE. | HENKEL KGAA (DE) | 1992-01-29 | — | — | EP | claimed |
| WO-1990012793-A1 | PROCESS FOR THE STEREO-SELECTIVE PRODUCTION OF 8α,12-OXIDO-13,14,15,16-TETRANORLABDANE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1990-11-01 | — | — | WO | claimed |
| EP-0107857-B1 | PROCESS FOR THE PREPARATION OF 8,12-EPOXY-13,14,15,16-TETRANOR LABDANE | Consortium für elektrochemische Industrie GmbH (DE) | 1986-12-30 | — | — | EP | claimed |
| US-4503240-A | Process for preparing 8,12-epoxy-13,14,15,16-tetranorlabdane | Consortium F/u/ r Elektrochemische Industrie GmbH (DE) | 1985-03-05 | — | — | US | claimed |
| EP-0107857-A1 | Process for the preparation of 8,12-epoxy-13,14,15,16-tetranor labdane | Consortium für elektrochemische Industrie GmbH (DE) | 1984-05-09 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160168109-A1 | METHOD FOR PRODUCING N,N-DIALKYLHOMOFARNESIC ACID AMIDE | HRH2, FAAH2, FAAH | ALDH1A1 295/4885CYP3A4 679/4885CYP2C9 275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.